FDA Inspection 1282008 — Herbert Ho Loong
The FDA completed an inspection of Herbert Ho Loong on Aug 22, 2025 in Shatin, N.T., HKSAR. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 22, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Shatin, N.T., HKSAR (Hong Kong SAR)
Additional Details
Clinical Investigator (CI)